Search

Author/Creator Faedi, M

1. OS2.3 Updated results of REGOMA: A randomized, multicenter, controlled open-label phase II clinical trial evaluating regorafenib in relapsed glioblastoma <GBM> patients <PTS>. (19th September 2018)

Authors:
Lombardi, G; de Salvo, G; Rudà, R; Franceschi, E; Eoli, M; Faedi, M; Pace, A; Lolli, I; Rizzato, S; Germano, D; Pasqualetti, F; Farina, M; Magni, G; Bellu, L; Caccese, M; Pambuku, A; Bergo, E; Indraccolo, S; Gardiman, M; Soffietti, R
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 3
Page Start:
iii219
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P01.040 Identification of a predictive biomarker of response to regorafenib in relapsed glioblastoma patients <REGOMA trial>. (19th September 2018)

Authors:
Lombardi, G; Indraccolo, S; de Salvo, G; Verza, M; Magni, G; Eoli, M; Rudà, R; Franceschi, E; Faedi, M; Lolli, I; Rizzato, S; Caccese, M; Gardiman, M; Zagonel, V
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 3
Page Start:
iii237
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P01.040 Identification of a predictive biomarker of response to regorafenib in relapsed glioblastoma patients <REGOMA trial>. (19th September 2018)

Authors:
Lombardi, G; Indraccolo, S; de Salvo, G; Verza, M; Magni, G; Eoli, M; Rudà, R; Franceschi, E; Faedi, M; Lolli, I; Rizzato, S; Caccese, M; Gardiman, M; Zagonel, V
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 3
Page Start:
iii237
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search